4 European Projects Found
Searched on 125080 European Projects
FINISHED
Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections (COMBACTE-MAGNET)
Start date: Jan 1, 2015, End date: Dec 31, 2021,
...t P. aeruginosa infection in critically ill patients and to develop new antibiotics for infections caused by Gram-negative bacteria (GNB). The Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections (COMBACTE-MAGNET) consortium will provide groundbreaking multinational phase 2 and phase 3 studies in adult intensive care unit (ICU) patients and a phase 1 paediatric sa ...
Read Project
44
Partners Participants
FINISHED
Elucidating Pathways of Steatohepatitis (EPoS)
Start date: May 1, 2015, End date: Apr 30, 2019,
Strongly associated with the epidemics of obesity and type 2 diabetes mellitus (T2DM) that are testing healthcare systems worldwide, Non-Alcoholic Fatty Liver Disease (NAFLD) is an increasingly common cause of advanced liver disease in the aging population of Europe. NAFLD is a spectrum of hepatic fat accumulation (steatosis); steatosis plus inflammation (non-alcoholic steatohepatitis, NASH); fibr ...
Read Project
13
Partners Participants
FINISHED
Metagenomics in Cardiometabolic Diseases (METACARDIS)
Start date: Nov 1, 2012, End date: Oct 31, 2018,
METACARDIS applies a systems medicine multilevel approach to identify biological relationships between gut microbiota, assessed by metagenomics, and host genome expression regulation, which will improve understanding and innovative care of cardiometabolic diseases (CMD) and their comorbidities. CMD comprise metabolic (obesity, diabetes) and heart diseases characterized by a chronic evolution in ag ...
Read Project
18
Partners Participants
FINISHED
"Therapeutic Beta-Lactam Monitoring for Stratified Treatment of hospital-acquired pneumonia, improved dose-dependent efficacy, decreased treatment duration, and prevention of emergence of resistance" (MON4STRAT)
Start date: Feb 1, 2014, End date: Jan 31, 2018,
...mperfectly fit individual patient’s needs due to large, rapid and difficult-to-predict variations of blood levels.Current methods for monitoring β-lactam blood levels are slow and require complex instruments not usable at bed-side. Yet, generating easily, rapidly and cost-effectively real data usable at the patient’s bed-side should improve outcomes of β-lactam treatments. This is what 3 out of t ...
Read Project
